A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non–Small Cell Lung Cancer

Patient-derived xenograft (PDX) models are an effective preclinical in vivo platform for testing the efficacy of novel drugs and drug combinations for cancer therapeutics. Here we describe a repository of 79 genomically and clinically annotated lung cancer PDXs available from The Jackson Laboratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Xing Yi, Srivastava, Anuj, Mack, Philip C., Graber, Joel H., Sanderson, Brian J., Lloyd, Michael W., Chen, Mandy, Domanskyi, Sergii, Gandour-Edwards, Regina, Tsai, Rebekah A., Keck, James, Cheng, Mingshan, Bundy, Margaret, Jocoy, Emily L., Riess, Jonathan W., Holland, William, Grubb, Stephen C., Peterson, James G., Stafford, Grace A., Paisie, Carolyn, Neuhauser, Steven B., Karuturi, R. Krishna Murthy, George, Joshy, Simons, Allen K., Chavaree, Margaret, Tepper, Clifford G., Goodwin, Neal, Airhart, Susan D., Lara, Primo N., Openshaw, Thomas H., Liu, Edison T., Gandara, David R., Bult, Carol J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Resource Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664138/
https://www.ncbi.nlm.nih.gov/pubmed/36069866
http://dx.doi.org/10.1158/0008-5472.CAN-22-0948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664138/
https://www.ncbi.nlm.nih.gov/pubmed/36069866
http://dx.doi.org/10.1158/0008-5472.CAN-22-0948

Ejemplares similares